Note to our followers: Due to a lack of sufficient funding, HealthNewsReview.org will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Category: FDA

3 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

8 4/20/2016

Media mystery: Why did journalists ignore an important study on a costly, harmful back pain procedure?

4 3/16/2016

Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing

1 2/29/2016

Precision Medicine at one year: A soaring White House summit and the potholes ahead

7 2/10/2016

Groups push pharma agenda under the guise of patient advocacy

1/15/2016

Faulty medical devices stay on the market even after manufacturers know there are problems

3 1/7/2016

“Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny

5 1/5/2016

FDA teams up with medical device industry to write 21st Century Cures Act

9 12/16/2015

Opdivo ads vs. the reality of stage IV cancer treatment

5 11/19/2015

Media ignore impact of unsafe medical devices — unless the company CEO is a celebrity billionaire like Elizabeth Holmes